Resources
A collection of feature articles, case studies, and whitepapers from CAS. News and trends spanning scientific research and information technology.
White papers
The rise of biologics: Emerging trends and opportunities
Biologics research and production have grown rapidly in the past few decades, with no signs of slowing down. As innovators navigate an increasingly varied landscape of biological drugs designed to target everything from cancer to infectious diseases, many challenges still face those developing these next-generation therapeutics.
Read More
White papers
Emerging Trends in Drug Delivery
Emerging Trends in Drug Delivery is a CAS whitepaper which highlights four technologies that have shown particular growth in recent years and are expected to be key innovation areas in the future.
Read More
White papers
Global Science & Technology Trends Report - Therapeutic Fusion Protein R&D
With rapid advances in recombinant DNA and protein engineering technologies, therapeutic fusion proteins have emerged as a new option for biologics with improved pharmacokinetic stability and enhanced capability to act on molecular targets. Fusion proteins have also facilitated the development of new vaccines, and gene and cell therapy drugs to address other clinical challenges.
Read More
White papers
Global Science & Technology Trends Report: Gene and Cell Therapy R&D
This CAS white paper identifies major trends in gene and cell therapy R&D that may help to predict future developments and pinpoint opportunities for therapeutic applications in the treatment of various diseases.
Read More
White papers
Five Often Overlooked IP Gaps That Can Derail Your Innovation Strategy
Download this CAS whitepaper and learn five often overlooked IP gaps that can hinder innovation strategy.
Read More
White papers
CAS IP Research: Opportunities for Accelerating Innovation and Mitigating Risk at the Nexus of Intellectual Property and R&D
This CAS whitepaper explores the transformation of IP and R&D, where organizations apply IP insights to accelerate breakthroughs and identify potential risks to commercialization earlier in the product lifecycle.
Read More
White papers
Chemical Inhibitors to RAS Oncoproteins
This white paper presents an analysis of the RAS inhibitor landscape, with views based on structural similarity, chemical properties, and patent assignees. See what the insights reveal.
Read More